Insilco Ltd
Insilco Limited was incorporated in 1988. It is a subsidiary of Evonik Operations GmbH, Germany. The Company is engaged in the manufacturing and selling of precipitated silica. It produces different grades of precipitated silica, catering to the requirements of customers in different industries.
[1][2]
- Market Cap ₹ 52.4 Cr.
- Current Price ₹ 8.36
- High / Low ₹ /
- Stock P/E
- Book Value ₹ 0.99
- Dividend Yield 0.00 %
- ROCE -9.47 %
- ROE -11.9 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
Cons
- Stock is trading at 8.40 times its book value
- Company has low interest coverage ratio.
- Company has a low return on equity of -17.5% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Metals & Mining Minerals & Mining Industrial Minerals
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 61.34 | 56.71 | 72.59 | 86.64 | 86.58 | 95.15 | 57.75 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 73.52 | 58.56 | 71.77 | 85.53 | 88.58 | 102.06 | 70.46 | 59.71 | 12.48 | 10.22 | 7.27 | 4.50 | 4.04 | |
| Operating Profit | -12.18 | -1.85 | 0.82 | 1.11 | -2.00 | -6.91 | -12.71 | -59.71 | -12.48 | -10.22 | -7.27 | -4.50 | -4.04 |
| OPM % | -19.86% | -3.26% | 1.13% | 1.28% | -2.31% | -7.26% | -22.01% | ||||||
| 2.72 | 4.45 | 2.70 | 6.25 | 3.98 | 3.58 | 5.27 | 4.71 | 1.76 | 2.65 | 41.66 | 2.24 | 0.61 | |
| Interest | 0.01 | 0.01 | 0.31 | 0.01 | 0.02 | 0.32 | 0.01 | 0.64 | 0.04 | 0.01 | 0.00 | 0.00 | 0.00 |
| Depreciation | 2.50 | 1.16 | 1.33 | 1.72 | 1.92 | 2.46 | 2.83 | 2.00 | 0.02 | 0.02 | 0.01 | 0.00 | 0.00 |
| Profit before tax | -11.97 | 1.43 | 1.88 | 5.63 | 0.04 | -6.11 | -10.28 | -57.64 | -10.78 | -7.60 | 34.38 | -2.26 | -3.43 |
| Tax % | -13.87% | 0.00% | 21.28% | 12.97% | -800.00% | -1.31% | 1.95% | 0.12% | -1.21% | 6.58% | 8.78% | 24.78% | |
| -10.31 | 1.42 | 1.48 | 4.91 | 0.36 | -6.04 | -10.47 | -57.72 | -10.65 | -8.09 | 31.36 | -2.83 | -3.58 | |
| EPS in Rs | -1.64 | 0.23 | 0.24 | 0.78 | 0.06 | -0.96 | -1.67 | -9.20 | -1.70 | -1.29 | 5.00 | -0.45 | -0.58 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 12% |
| 3 Years: | 20% |
| TTM: | -33% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -7% |
| 5 Years: | 5% |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | -15% |
| 5 Years: | -58% |
| 3 Years: | -18% |
| Last Year: | -12% |
Balance Sheet
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 62.72 | 62.72 | 62.72 | 62.72 | 62.72 | 62.72 | 62.72 | 62.72 | 62.72 | 62.72 | 62.72 | 33.99 | 0.00 |
| Reserves | 26.79 | 26.82 | 28.13 | 37.93 | 38.50 | 32.22 | 21.46 | -35.69 | -46.34 | -54.44 | -23.07 | -25.90 | 6.24 |
| 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.27 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 5.09 | 5.96 | 6.42 | 6.26 | 8.53 | 10.11 | 4.54 | 10.12 | 27.01 | 46.32 | 3.93 | 2.19 | 0.28 | |
| Total Liabilities | 94.60 | 95.50 | 97.27 | 106.92 | 109.76 | 105.06 | 88.99 | 37.16 | 43.39 | 54.60 | 43.58 | 10.28 | 6.52 |
| 17.72 | 15.70 | 14.91 | 16.37 | 18.33 | 22.18 | 22.34 | 5.88 | 0.03 | 0.02 | 0.00 | 0.00 | 0.00 | |
| CWIP | 0.02 | 0.09 | 1.41 | 0.43 | 1.92 | 0.96 | 0.52 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 36.09 | 32.42 | 31.42 | 37.64 | 25.97 | 19.33 | 18.26 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 40.77 | 47.29 | 49.53 | 52.48 | 63.54 | 62.59 | 47.87 | 31.28 | 43.36 | 54.58 | 43.58 | 10.28 | 6.52 | |
| Total Assets | 94.60 | 95.50 | 97.27 | 106.92 | 109.76 | 105.06 | 88.99 | 37.16 | 43.39 | 54.60 | 43.58 | 10.28 | 6.52 |
Cash Flows
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -6.16 | -4.68 | -6.59 | 3.73 | 1.67 | -4.30 | 6.11 | -34.22 | 5.61 | 9.55 | -44.72 | -3.00 | |
| 9.34 | 1.17 | 6.17 | -3.02 | -1.67 | 4.38 | -6.19 | 35.98 | -5.54 | -7.60 | 79.07 | -4.79 | |
| 0.00 | -0.01 | -0.01 | -0.01 | -0.02 | -0.32 | -0.05 | -0.66 | -0.04 | -0.01 | 0.00 | -27.36 | |
| Net Cash Flow | 3.18 | -3.52 | -0.43 | 0.69 | -0.02 | -0.24 | -0.13 | 1.10 | 0.03 | 1.95 | 34.35 | -35.15 |
| Free Cash Flow | -5.93 | -5.41 | -8.94 | 1.21 | -3.59 | -9.86 | 3.37 | -34.21 | 5.65 | 9.79 | -11.19 | -3.00 |
| CFO/OP | 51% | 253% | -783% | 320% | -41% | 59% | -44% | 57% | -37% | -98% | 594% | 21% |
Ratios
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 58.20 | 62.37 | 96.44 | 77.77 | 75.55 | 63.60 | 1.96 | |||||
| Inventory Days | 161.14 | 263.84 | 150.49 | 101.21 | 102.22 | 99.17 | 32.96 | |||||
| Days Payable | 26.43 | 42.69 | 33.18 | 30.68 | 59.59 | 64.01 | 22.71 | |||||
| Cash Conversion Cycle | 192.90 | 283.51 | 213.75 | 148.31 | 118.17 | 98.76 | 12.20 | |||||
| Working Capital Days | 92.83 | 121.45 | 131.09 | 99.63 | 93.13 | 74.00 | 10.43 | |||||
| ROCE % | -13.71% | -0.99% | 1.09% | 6.35% | 0.03% | -5.42% | -11.36% | -102.63% | -49.65% | -63.42% | 2.80% | -9.47% |
Insights
In beta| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capacity Utilization (of Effective Capacity) % |
|
|||||||||||
| Installed Capacity MT |
||||||||||||
| Production Volume MT |
||||||||||||
| Sales Volume MT |
||||||||||||
| Effective Installed Capacity (Excluding Impaired) MT |
||||||||||||
Documents
Announcements
-
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
1d - Appointed Ms. Shivangi Negi as MD (14 Feb 2026–13 Feb 2031); Ms. Deepa Jha appointed director.
- Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot 1d
-
Closure of Trading Window
25 Mar - Trading window closed April 1, 2026 until 48 hours after audited FY ended March 31, 2026.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
16 Mar - Newspaper Publication- Public Notice of Shareholders - Special window for Re-Lodgement of Transfer Request for Physical Shares
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
25 Feb - Newspaper Advertisement- Notice of Postal Ballot of Insilco Limited
Annual reports
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Products & Services
Sipernat: It is silica that combines a high absorption capacity together with adequate flowability. It is used in the feed industry as a carrier silica for choline chloride solutions, vitamin E acetate, and other liquid active substances.
Ultrasil: Precipitated silica for use as reinforcement filler in the rubber industry. [1][2]